Stericycle (SRCL) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

SRCL Stock Forecast


Stericycle stock forecast is as follows: an average price target of $62.00 (represents a 0.03% upside from SRCL’s last price of $61.98) and a rating consensus of 'Hold', based on 2 wall street analysts offering a 1-year stock forecast.

SRCL Price Target


The average price target for Stericycle (SRCL) is $62.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $62.00 to $62.00. This represents a potential 0.03% upside from SRCL's last price of $61.98.

SRCL Analyst Ratings


Hold

According to 2 Wall Street analysts, Stericycle's rating consensus is 'Hold'. The analyst rating breakdown for SRCL stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 2 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Stericycle Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 20, 2024Michael HoffmanStifel Nicolaus$62.00$58.446.09%0.03%
Jun 03, 2024Sector PerformRBC Capital$62.00$59.055.00%0.03%
Jun 03, 2024Michael HoffmanStifel Nicolaus$75.00$51.5445.52%21.01%
Apr 18, 2023Tobey SommerTruist Financial$45.00$41.807.66%-27.40%

The latest Stericycle stock forecast, released on Jun 20, 2024 by Michael Hoffman from Stifel Nicolaus, set a price target of $62.00, which represents a 6.09% increase from the stock price at the time of the forecast ($58.44), and a 0.03% increase from SRCL last price ($61.98).

Stericycle Price Target by Period


1M3M12M
# Anlaysts--3
Avg Price Target--$66.33
Last Closing Price$61.98$61.98$61.98
Upside/Downside-100.00%-100.00%7.02%

In the current month, the average price target of Stericycle stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Stericycle's last price of $61.98. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Jun 04, 2024Truist FinancialSector PerformSector PerformHold
Jun 03, 2024RBC CapitalOutperformSector PerformDowngrade
Feb 29, 2024RBC CapitalOutperformOutperformHold
Aug 08, 2022RBC CapitalOutperformOutperformHold

Stericycle's last stock rating was published by Truist Financial on Jun 04, 2024. The company gave SRCL a "Sector Perform" rating, the same as its previous rate.

Stericycle Financial Forecast


Stericycle Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$652.00M$653.50M$669.50M$684.30M$670.40M$690.30M$679.80M$664.20M$657.30M$648.90M$672.70M$668.00M$655.90M$636.40M$598.20M$785.00M$799.90M$833.10M
Avg Forecast$711.30M$714.30M$702.90M$705.20M$704.00M$703.00M$694.00M$685.00M$672.09M$669.38M$667.45M$676.42M$657.99M$679.03M$683.48M$670.38M$697.18M$675.21M$674.64M$671.00M$659.84M$671.71M$669.15M$648.52M$651.10M$642.84M$595.59M$795.22M$807.68M$842.21M
High Forecast$711.30M$714.30M$702.90M$705.20M$704.00M$703.00M$694.00M$685.00M$672.09M$671.60M$667.45M$677.95M$666.52M$679.03M$683.48M$670.38M$697.18M$675.21M$674.64M$671.00M$659.84M$671.71M$669.15M$648.52M$651.10M$642.84M$595.59M$795.22M$807.68M$842.21M
Low Forecast$711.30M$714.30M$702.90M$705.20M$704.00M$703.00M$694.00M$685.00M$672.09M$667.16M$667.45M$674.88M$654.01M$679.03M$683.48M$670.38M$697.18M$675.21M$674.64M$671.00M$659.84M$671.71M$669.15M$648.52M$651.10M$642.84M$595.59M$795.22M$807.68M$842.21M
# Analysts111111111213633344443333999955
Surprise %------------0.99%0.96%0.98%1.02%0.96%1.02%1.01%0.99%1.00%0.97%1.01%1.03%1.01%0.99%1.00%0.99%0.99%0.99%

Stericycle's average Quarter revenue forecast for Mar 24 based on 3 analysts is $676.42M, with a low forecast of $674.88M, and a high forecast of $677.95M. SRCL's average Quarter revenue forecast represents a 3.74% increase compared to the company's last Quarter revenue of $652.00M (Dec 23).

Stericycle EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111111213633344443333999955
EBITDA------------$37.10M$24.20M$-24.00M$100.00M$43.40M$111.60M$95.20M$64.80M$64.10M$6.50M$111.30M$113.60M$147.20M$700.00K$83.70M$26.40M$-135.20M$29.80M
Avg Forecast$94.54M$94.94M$93.43M$93.73M$93.57M$93.44M$92.24M$91.05M$89.33M$88.97M$88.71M$102.11M$87.46M$90.25M$90.84M$92.83M$84.01M$89.75M$89.67M$84.39M$87.70M$89.28M$88.94M$90.49M$86.54M$85.44M$79.16M$28.72M$107.35M$111.94M
High Forecast$94.54M$94.94M$93.43M$93.73M$93.57M$93.44M$92.24M$91.05M$89.33M$89.27M$88.71M$122.54M$88.59M$90.25M$90.84M$111.40M$100.81M$89.75M$89.67M$101.27M$87.70M$89.28M$88.94M$108.59M$86.54M$85.44M$79.16M$34.46M$107.35M$111.94M
Low Forecast$94.54M$94.94M$93.43M$93.73M$93.57M$93.44M$92.24M$91.05M$89.33M$88.68M$88.71M$81.69M$86.93M$90.25M$90.84M$74.26M$67.21M$89.75M$89.67M$67.51M$87.70M$89.28M$88.94M$72.40M$86.54M$85.44M$79.16M$22.97M$107.35M$111.94M
Surprise %------------0.42%0.27%-0.26%1.08%0.52%1.24%1.06%0.77%0.73%0.07%1.25%1.26%1.70%0.01%1.06%0.92%-1.26%0.27%

3 analysts predict SRCL's average Quarter EBITDA for Mar 24 to be $102.11M, with a high of $122.54M and a low of $81.69M. This is 175.24% upper than Stericycle's previous annual EBITDA (Dec 23) of $37.10M.

Stericycle Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111111213633344443333999955
Net Income------------$14.90M$11.70M$-49.50M$11.20M$31.80M$28.00M$10.50M$-14.10M$-16.40M$-66.00M$29.30M$26.10M$48.50M$-81.20M$-4.50M$-20.10M$-219.30M$-59.20M
Avg Forecast$79.72M$68.60M$69.53M$69.53M$70.45M$63.96M$61.18M$50.98M$53.88M$51.33M$50.70M$-22.41M$43.30M$42.02M$45.27M$-20.37M$-22.54M$54.13M$44.48M$-18.52M$43.26M$55.49M$64.25M$20.79M$58.80M$52.25M$26.40M$-21.86M$64.59M$63.34M
High Forecast$79.72M$68.60M$69.53M$69.53M$70.45M$63.96M$61.18M$50.98M$53.88M$52.22M$50.70M$-17.93M$46.99M$42.04M$45.27M$-16.30M$-18.03M$54.13M$44.48M$-14.82M$43.26M$55.49M$64.25M$24.95M$58.80M$52.25M$26.40M$-17.49M$64.59M$63.34M
Low Forecast$79.72M$68.60M$69.53M$69.53M$70.45M$63.96M$61.18M$50.98M$53.88M$49.56M$50.69M$-26.89M$41.46M$42.01M$45.27M$-24.45M$-27.05M$54.13M$44.48M$-22.23M$43.26M$55.49M$64.25M$16.63M$58.80M$52.25M$26.40M$-26.24M$64.59M$63.34M
Surprise %------------0.34%0.28%-1.09%-0.55%-1.41%0.52%0.24%0.76%-0.38%-1.19%0.46%1.26%0.82%-1.55%-0.17%0.92%-3.40%-0.93%

Stericycle's average Quarter net income forecast for Mar 24 is $-22.41M, with a range of $-26.89M to $-17.93M. SRCL's average Quarter net income forecast represents a -250.41% decrease compared to the company's last Quarter net income of $14.90M (Dec 23).

Stericycle SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111111213633344443333999955
SG&A------------$219.70M$217.30M$220.90M$216.00M$210.90M$215.60M$222.40M$238.60M$251.40M$279.40M$213.50M$202.30M$218.90M$219.00M$201.00M$258.70M$250.00M$247.40M
Avg Forecast$228.47M$229.43M$225.77M$226.51M$226.13M$225.81M$222.91M$220.02M$215.88M$215.01M$214.39M$376.57M$211.35M$218.11M$219.53M$342.34M$329.49M$216.88M$216.70M$311.22M$211.94M$215.75M$214.93M$161.15M$209.13M$206.48M$191.31M$281.39M$259.43M$270.52M
High Forecast$228.47M$229.43M$225.77M$226.51M$226.13M$225.81M$222.91M$220.02M$215.88M$215.72M$214.39M$451.89M$214.09M$218.11M$219.53M$410.81M$395.39M$216.88M$216.70M$373.46M$211.94M$215.75M$214.93M$193.39M$209.13M$206.48M$191.31M$337.67M$259.43M$270.52M
Low Forecast$228.47M$229.43M$225.77M$226.51M$226.13M$225.81M$222.91M$220.02M$215.88M$214.29M$214.39M$301.26M$210.07M$218.11M$219.53M$273.87M$263.60M$216.88M$216.70M$248.97M$211.94M$215.75M$214.93M$128.92M$209.13M$206.48M$191.31M$225.11M$259.43M$270.52M
Surprise %------------1.04%1.00%1.01%0.63%0.64%0.99%1.03%0.77%1.19%1.29%0.99%1.26%1.05%1.06%1.05%0.92%0.96%0.91%

Stericycle's average Quarter SG&A projection for Mar 24 is $376.57M, based on 3 Wall Street analysts, with a range of $301.26M to $451.89M. The forecast indicates a 71.40% rise compared to SRCL last annual SG&A of $219.70M (Dec 23).

Stericycle EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111111213633344443333999955
EPS------------$0.16$0.13$-0.54$0.12$0.35$0.30$0.11$-0.15$-0.18$-0.72$0.32$0.29$0.53$-0.89$-0.05$-0.22$-2.41$-0.65
Avg Forecast$0.86$0.74$0.75$0.75$0.76$0.69$0.66$0.55$0.58$0.55$0.55$0.56$0.47$0.45$0.49$0.44$0.60$0.58$0.48$0.46$0.47$0.60$0.69$0.59$0.63$0.56$0.28$0.58$0.69$0.68
High Forecast$0.86$0.74$0.75$0.75$0.76$0.69$0.66$0.55$0.58$0.56$0.55$0.56$0.51$0.45$0.49$0.44$0.60$0.58$0.48$0.46$0.47$0.60$0.69$0.59$0.63$0.56$0.28$0.58$0.69$0.68
Low Forecast$0.86$0.74$0.75$0.75$0.76$0.69$0.66$0.55$0.58$0.53$0.55$0.55$0.45$0.45$0.49$0.44$0.60$0.58$0.48$0.46$0.47$0.60$0.69$0.59$0.63$0.56$0.28$0.58$0.69$0.68
Surprise %------------0.34%0.29%-1.11%0.27%0.58%0.52%0.23%-0.32%-0.39%-1.21%0.46%0.49%0.84%-1.58%-0.18%-0.38%-3.47%-0.95%

According to 3 Wall Street analysts, Stericycle's projected average Quarter EPS for Mar 24 is $0.56, with a low estimate of $0.55 and a high estimate of $0.56. This represents a 247.24% increase compared to SRCL previous annual EPS of $0.16 (Dec 23).

Stericycle Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
MEGMontrose Environmental Group$17.51$43.00145.57%Buy
CLHClean Harbors$239.54$271.5013.34%Buy
CWSTCasella Waste Systems$106.50$119.2511.97%Buy
RSGRepublic Services$205.62$227.5010.64%Buy
GFLGFL Environmental$44.56$48.679.22%Buy
WCNWaste Connections$176.26$192.509.21%Buy

SRCL Forecast FAQ


Is Stericycle a good buy?

No, according to 2 Wall Street analysts, Stericycle (SRCL) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of SRCL's total ratings.

What is SRCL's price target?

Stericycle (SRCL) average price target is $62 with a range of $62 to $62, implying a 0.03% from its last price of $61.98. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Stericycle stock go up soon?

According to Wall Street analysts' prediction for SRCL stock, the company can go up by 0.03% (from the last price of $61.98 to the average price target of $62), up by 0.03% based on the highest stock price target, and up by 0.03% based on the lowest stock price target.

Can Stericycle stock reach $90?

SRCL's average twelve months analyst stock price target of $62 does not support the claim that Stericycle can reach $90 in the near future.

What are Stericycle's analysts' financial forecasts?

Stericycle's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $2.79B (high $2.79B, low $2.79B), average EBITDA is $370.3M (high $370.3M, low $370.3M), average net income is $246.58M (high $246.58M, low $246.58M), average SG&A $894.87M (high $894.87M, low $894.87M), and average EPS is $2.66 (high $2.66, low $2.66). SRCL's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $2.83B (high $2.83B, low $2.83B), average EBITDA is $376.64M (high $376.64M, low $376.64M), average net income is $287.37M (high $287.37M, low $287.37M), average SG&A $910.19M (high $910.19M, low $910.19M), and average EPS is $3.1 (high $3.1, low $3.1).

Did the SRCL's actual financial results beat the analysts' financial forecasts?

Based on Stericycle's last annual report (Dec 2023), the company's revenue was $2.66B, which missed the average analysts forecast of $2.69B by -1.17%. Apple's EBITDA was $77.3M, missing the average prediction of $361.38M by -78.61%. The company's net income was $-21.4M, missing the average estimation of $110.22M by -119.42%. Apple's SG&A was $873.9M, missing the average forecast of $991.33M by -11.85%. Lastly, the company's EPS was $-0.23, missing the average prediction of $1.85 by -112.46%. In terms of the last quarterly report (Dec 2023), Stericycle's revenue was $652M, missing the average analysts' forecast of $657.99M by -0.91%. The company's EBITDA was $37.1M, missing the average prediction of $87.46M by -57.58%. Stericycle's net income was $14.9M, missing the average estimation of $43.3M by -65.59%. The company's SG&A was $219.7M, beating the average forecast of $211.35M by 3.95%. Lastly, the company's EPS was $0.16, missing the average prediction of $0.467 by -65.75%